Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial

Authors: Dean A Fennell, Amy King, Seid Mohammed, Amy Branson, Cassandra Brookes, Liz Darlison, Alan G Dawson, Aarti Gaba, Margaret Hutka, Bruno Morgan, Adrian Nicholson, Cathy Richards, Peter Wells-Jordan, Gavin James Murphy, Anne Thomas, Dean Anthony Fennell, Amy King, Seid Mohammed, Amy Branson, Cassandra Brooks, Liz Darlison, Alan George Dawson, Aarti Gaba, Margaret Hutka, Bruno Morgan, Adrian Nicholson, Cathy Richards, Peter Wells-Jordan, Gavin James Murphy, Anne Thomas, Sarah Anthony, Vina Bhundia, Caroline Cowley, Charlotte Poile, Molly Scotland

Published: 2021-01-27

DOI: 10.1016/s2213-2600(20)30390-8

Source: Full article

---

Abstract

No abstract found.